Manoj Tyagi
Overview
Explore the profile of Manoj Tyagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
733
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung H, Rajan S, Wu Z, Ferrone C, Raffeld M, Lee I, et al.
Acta Neuropathol
. 2024 Oct;
148(1):54.
PMID: 39422766
Astrocytomas that harbor recurrent genomic alterations in MYB or MYBL1 are a group of Pediatric-type diffuse low-grade gliomas that were newly recognized in the 2021 WHO Classification of Tumors of...
2.
Snozek C, Yee C, Bryksin J, Dahal R, Gerson B, Gherasim C, et al.
Am J Clin Pathol
. 2024 Jul;
163(1):69-79.
PMID: 39066575
Objectives: Urine drug testing (UDT) is a critical tool used in medical, forensic, and occupational settings, but interpreting results can be challenging. We performed a study to assess the ability...
3.
Raygada M, John L, Liu A, Schultz J, Thomas B, Bernstein D, et al.
J Cancer Res Clin Oncol
. 2024 May;
150(5):227.
PMID: 38700789
Introduction: Chordoma is a rare slow-growing tumor that occurs along the length of the spinal axis and arises from primitive notochordal remnants (Stepanek et al., Am J Med Genet 75:335-336,...
4.
Ahmed S, Wedekind M, Del Rivero J, Raygada M, Lockridge R, Glod J, et al.
Cancer Res Commun
. 2023 Nov;
3(12):2468-2482.
PMID: 37966258
Significance: This study demonstrates that comprehensive, tumor-agnostic data and biospecimen collection is feasible to characterize different rare tumors, and speed progress in research. The findings will be foundational to developing...
5.
Abel M, Takahashi N, Peer C, Redon C, Nichols S, Vilimas R, et al.
Clin Cancer Res
. 2023 May;
29(18):3603-3611.
PMID: 37227187
Purpose: Despite promising preclinical studies, toxicities have precluded combinations of chemotherapy and DNA damage response (DDR) inhibitors. We hypothesized that tumor-targeted chemotherapy delivery might enable clinical translation of such combinations....
6.
Saksena A, Jain A, Pack S, Kim J, Lee I, Tyagi M, et al.
Am J Surg Pathol
. 2022 Dec;
47(3):409-419.
PMID: 36461146
Primary cutaneous follicle center lymphoma has been distinguished from nodal follicular lymphoma (FL) based on genomic and clinical features. The nature of other extranodal FLs is not well defined. We...
7.
Wu Z, Rajan S, Chung H, Raffeld M, Panneer Selvam P, Schweizer L, et al.
Acta Neuropathol
. 2022 Oct;
144(6):1175-1178.
PMID: 36201019
No abstract available.
8.
Merchant M, Raygada M, Pang Y, Quezado M, Raffeld M, Xi L, et al.
Front Oncol
. 2022 Aug;
12:954879.
PMID: 35982947
Most tumors, including brain tumors, are sporadic. However, a small subset of CNS tumors are associated with hereditary cancer conditions like Lynch Syndrome (LS). Here, we present a case of...
9.
Zhou T, Cheng J, Karrs J, Davies-Hill T, Pack S, Xi L, et al.
Am J Surg Pathol
. 2022 Jun;
46(10):1364-1379.
PMID: 35650679
Epstein-Barr virus (EBV)-positive plasmacytoma is a rare plasma cell neoplasm. It remains unclear whether EBV-positive plasmacytoma represents a distinct entity or a variant of plasmacytoma. It shares morphologic features with...
10.
Brohl A, Sindiri S, Wei J, Milewski D, Chou H, Song Y, et al.
Cell Rep
. 2021 Nov;
37(8):110047.
PMID: 34818552
We perform an immunogenomics analysis utilizing whole-transcriptome sequencing of 657 pediatric extracranial solid cancer samples representing 14 diagnoses, and additionally utilize transcriptomes of 131 pediatric cancer cell lines and 147...